FDA Investigator Dawn L Wydner
Dawn L Wydner has conducted inspections on 153 sites in 9 countries as of 16 Aug 2011. See below for a list of the FDA enforcement documents resulting from those inspections.
Investigator Details
Number of Inspected Sites:
153
Last Inspection Date:
16 Aug 2011
Investigator Role:
FDA Investigator
Redica ID:
Countries of Inspections:
United States of America,
Bulgaria,
United Kingdom of Great Britain and Northern Ireland,
Denmark,
Hong Kong,
Romania,
China,
Italy,
Thailand
FDA Investigators that have inspected at least one site in common with Dawn L Wydner:
Addam S Reynolds,
Adetutu M Gidado,
Aditi S Thakur,
Albert M Brindle,
Alberto A Viciedo,
Allen Lou,
Althea A Williams,
Amy Franklin,
Amy Kim,
Amy L Singer,
Amy Lynn Frankshun, PhD,
Amy M Codella,
Amy M Cramer,
Ana S Cabrera,
Anastasia I Offordile,
Ankur C Patel,
Ann Marie Montemurro,
Ann Marie Schofield,
Anna R Kwilas,
Annemarie B Randow,
Annemarie Bodnar,
Arindam Dasgupta, PhD,
Atul J Agrawal,
Barbara J Maulfair,
Barbara Janine Breithaupt,
Barbara Jwilimczyk Macri,
Burnell M Henry,
Byungja E Marciante,
Carol A Perry,
Carol A Robles,
Cary Greene,
Charles Yuanchia Kuo, PhD,
Charlotte P Chang,
Christian D Lynch (CDL),
Christina N Maurino,
Christopher J Adams,
Creighton T Tuzon,
Daniel J Grabicki,
Darin S Wiegers,
David H Smith,
Deborah B Nixon,
Denise M Visco, Investigator,
Denise M Visu,
Dennis E Guilfoyle, PhD,
Dhaval H Patel,
Diane B Radice,
Dolores Harper,
Doreen P Canetti,
Doreen P Gubbay,
Dorothy J Denes,
Douglas C Kovacs,
Dr. Abhijit Raha, PhD,
Dr. Sriram Subramaniam, PhD,
Dr. Zhihao Qiu (Peter), PhD,
Edmund F Mrak, Jr,
Edward O'shaughnessy,
Emest F Bizjak,
Emily A Walters,
Emmanuel Jramos Maldonado,
Eric J Cunningham,
Eric Rothschild,
Erin D Mccaffery,
Esteban Beltran,
Eufemia G Gonzalez,
Frank J Marciniak,
Frederick F Razzaghi,
Gene D Arcy,
George Pyramides,
Gianine E Delade,
Gobiga Vanniyasingam,
Guerlain Ulysse,
Gwyn G Dickinson,
Haley H Seymour,
Helen B Ricalde,
Helen Verdel,
Hitesh R Patel,
Hyojong Kwon, PhD,
Iqra Iftikhar,
J David Doleski,
Jacqueline A O'shaughnessy, PhD,
Jacqueline Mdiaz Albertini,
Jacqueline S Warner,
James R Birkenstamm,
Janet A Rajan,
Janet Donnelly,
Jean Blackston Hill,
Jean M Kelahan,
Jean M Mulinde, MD,
Jennifer A Bazergui,
Jennifer L Custodio,
Jennifer Macmillan,
Jessica M Monteiro,
Joan A Loreng,
Joanne Pryzbylik,
Jonah S Ufferfilge,
Jonathan Ho,
Jonathan S Helfgott,
Jonee J Mearns,
Jose M Cayuela,
Jose Ohernandez Guzman,
Joseph F Mcginnis, RPh,
Joy Rkozlowski Klena,
Juanita P Versace,
Julie D Bringger,
Justine Tomasso,
Kara A Scheibner, PhD,
Karen E D'orazio,
Kathleen M Jordan,
Kelli F Dobilas,
Kelly I Anderson,
Kelly L Anderson,
Kimberly L Schultz,
Kimberly M Bigler,
Kinh Q Mac,
Kip J Hanks,
Kish Bolden,
Ko U Min,
Kristen E Rescigno,
Kristina L Conroy,
Kristy A Zielny,
Krystal O Ogunremi,
Kwong P Lee,
Kyle D Covill,
Laishan L Lam,
Lauren L Vajo,
Lawrence R Johnson,
LCDR Debra Emerson,
Leiyun Boone, PhD,
Lenahan Lenahan, Peter R,
Li Li,
Liatte Kreuger, PharmD,
Linda Thai,
Lisa Harlan,
Lisa Mathew,
Loretta Nemchik,
Marcellinus D Dordunoo,
Marcelo O Mangalindan, Jr,
Marcia Gelber,
Marea K Harmon,
Margaret M Sands,
Maria Estrella,
Marion Michaelis,
Mariza M Jafary,
Marjorie D Schultz,
Marlene G Swider,
Martha T Olone,
Martin K Yau, PhD,
Mary T Carden,
Matthew W Kyle,
Mayar M Mussa,
Meihong Liu,
Melissa A Freeman,
Melissa B Libby,
Melissa T Roy,
Melkamu Getie Kebtie, PhD,
Meredith L Sheridan,
Meyer J Slobotsky,
Michael F Skelly, PhD,
Michael R Klapal,
Michael Serrano,
Michael Skelly,
Michelle A Marsh,
Mohsen Rajabi Abhari, FDA,
Monica L Gutierrez,
Myoshi M Francis,
Nailing Zhang,
Nancy F Scheraga,
Nancy L Rolli,
Nancy M Espinal,
Nerizza B Dalena,
Nerizza B Guerin,
Nicholas A Violand,
Niketa Patel,
Nikisha M Bolden,
Nilufer M Tampal, PhD,
Nimmy Mathews,
Nina Yang,
Omotunde O Osunsanmi,
Patricia F Hughes, PhD,
Paul L Bellamy,
Paul Mouris,
Paula A Trost,
Peter R Lenahan,
Prabhu P Raju,
Qiao Y Bobo,
Raymond L Cheung,
Regina T Brown,
Remache,
Richard D Manney,
Richard E Needham,
Richard J Muzeni,
Robert G Ruff,
Rodrigo Vilchez,
Rose Ashley,
Russell J Glapion,
Ruth A Williams,
Saleem A Akhtar,
Sam Chan,
Samir C Gala,
Samuel Mindaye,
Sandra Kershaw,
Sarah Adella Fave,
Sarah Forney,
Schultz,
Sherri J Liu,
Sheryl A Kochman,
Shirley S Wen,
Simone E Pitts,
Sinai I Davis,
Stephanie T Durso,
Stephen J Koniers,
Stephen J Mottola,
Susan M Halsted,
Susan T Hadman,
Tamil Arasu, PhD,
Tania E Vizcaino,
Tara G Bizjak,
Tara R Gooen,
Teigan M Mule,
Teresita C Mercado,
Thuy T Nguyen, LCDR,
Tressa T Lewis,
Tyanna N Hadley,
Unnee Ranjan,
Valerie C Reed,
Valerie Reed,
Victoria Spivak,
Wayne E Seifert,
Wayne J Meyer,
William J Muszynski,
William R Chang,
William W Dotts,
Xiaohan Cai, PhD,
Xikui Chen (nmi), PhD,
Xingfang Li, MD,
Yan Wang,
Yvesna C Blaise
Dawn L Wydner's Documents
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more